ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,925
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
Author(s):
AD Cohen
,
S Parekh
,
BD Santomasso
,
J Gállego Pérez-Larraya
,
NWCJ Van de Donk
,
B. Arnulf
Publication date:
2022
Journal:
Blood Cancer J
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
oa journal (via doaj)
oa repository (via pmcid lookup)
Powered by
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Gamma Delta T cells
Author and article information
Journal
DOI::
10.1038/s41408-022-00629-1
PubMed ID::
34987165
ScienceOpen disciplines:
Immunology
Data availability:
ScienceOpen disciplines:
Immunology
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,925
Bortezomib, lenalidomide and dexamethasone (VRd) followed by ciltacabtagene autoleucel versus Vrd followed by lenalidomide and dexamethasone (Rd) maintenance in patients with newly diagnosed multiple myeloma not intended for transplant: A randomized, Phas
Authors:
D. Dytfeld
,
B Dhakal
,
M Agha
…
Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis.
Authors:
Sandra D'Angelo
,
Mihaela Druta
,
Brian Van Tine
…
SCiltacabtagene autoleucel a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Authors:
See all similar
Cited by
1
Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen
Authors:
Raya Aliakbar
,
Olga Manouvakhova
,
Cindy Wong
…
See all cited by